A study demonstrated in vivo therapeutic effects of intracranial delivery of chondroitin sulfate proteoglycan 4 (CSPG4)-CAR T-cells in nude mice transplanted with CSPG4-expressing glioma cells or GBM neurospheres models (43). The gene discussed is CSPG4; the disease is glioma.